A study on the effectiveness of the Siddha medicines Kungiliya Vennai and Karappan Thailam in improving symptoms of seborrheic dermatitis

A Clinical study on the effectiveness of kungiliya vennai and karappan thailam in the siddha management of mandai karappan (seborrheic dermatitis) - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2025/12/098670

Enrollment

Registered

2025-12-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L210- Seborrhea capitis

Interventions

Intervention1: kungiliya vennai(internal) karappan thailam(external): kungiliya vennai 5 grams BD morning and night (with elarasi) karappan thailam applied sufficient quantity on scalp for 48 days Con

Eligibility

Inclusion criteria

Inclusion criteria: Age 13 to 60 years Sex male, female, transgender erythema, scaling, and itching in scalp Mild to severe Seborrheic Dermatitis typically assessed using 16 POINT SCALE

Exclusion criteria

Exclusion criteria: psoriasis, eczema, rosacea, or other inflammatory skin conditions Participants who have used topical corticosteroids or systemic immunosuppressive drugs within 3 months Pregnancy and Lactation History of Skin Cancer

Design outcomes

Primary

Measure	Time frame
The determination of the therapeutic effectiveness of kungiliya vennai (internal) and karappan thailam (external) in the management of mandai karappan (seborrheic dermatitis) by reduction of the symptoms from severe, moderate to mild seborrheic dermatitis or absence of symptoms using 16-point scale.Timepoint: 6 Months	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr H Vetha merlin kumari

National institute of siddha

dr.vetha@gmail.com9894782366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026